bian zhe tui jian

..............page:1468

WINDOW OF NEW DRUGS
ben kan ;

..............page:1471-1472

Pharmacological and clinical evaluation of afatinib for the treatment of NSCLC
HUO Xiu-ying;FENG Yu-fei;Department of Pharmacy;Beijing Hospital;Ministry of Public Health;

..............page:1473-1476

Quality system for security of drug quality control data in laboratory computers
LI Jian;XIANG Xin-hua;CHEN Wei;National Institute for Food and Drug Control;

..............page:1477-1483

zhong guo xin yao za zhi guan fang wei bo he wei xin yao nin guan zhu

..............page:1483

Discussion on the countermeasure to the drug emergency inspection management
LIN Lan;GAO Zhi-feng;National Institute for Food and Drug Control;

..............page:1484-1486

Analysis of main problems for CMC changes of the post-approval chemical drugs
YANG Jian-hong;Center for Drug Evaluation;China Food and Drug Administration;

..............page:1487-1492+1524

Determination of lysolipid in vinorelbine liposome for injection by HPLC-charged aerosol detector
LI Han;GONG Wei;ZHANG Hui;MEI Xing-guo;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;

..............page:1493-1496

UPLC determination of ginsenoside Rh₁ and Rh₂ in secondary ginsenoside H dripping pill
ZHOU Hong-yu;WANG Yu;SONG Zhao-hui;ZHANG Lan-lan;ZHOU Shui-ping;FENG Feng;China Pharmaceutical University;Division of Modernized Traditional Chinese Medicine of Tasly Holding Group Academy;

..............page:1497-1500

Main points and inspirations of guidance for bioequivalence studies of oral solid products in European and American countries
ZHANG Yi-fan;ZHONG Da-fang;Shanghai Institute of Materia Medica;Chinese Academy of Sciences;

..............page:1501-1505

GastroPlus simulation technology for evaluating the bioequivalence of cefdinir capsules
PAN Rui-xue;YU Fang-jian;ZOU Wen-bo;HU Chang-qin;National Institutes for Food and Drug Control;

..............page:1506-1513

U.S.FDA drug safety information communication platform and drug quality reporting system
George R.Bolger;TU Yong-rui;SUN Pei-hua;XIE Guo-wei;QIAO Wei-dong;ZHANG Hong;Z-BioMed Inc.;Changzhou Siyao Pharm Co.;Ltd.;

..............page:1514-1520

Preparation and comparison of concealment allocation methods of alternative vaccine in double-blinded clinical vaccine trials
KONG Yu-jia;WANG Ling;JIANG Zhi-wei;LI Chan-juan;XIA Jie-lai;Department of Health Statistics;Faculty of Preventive Medicine;Fourth Military Medical University;

..............page:1521-1524

Advances in research of recombinant human endostatin(Endostar) in the treatment of lung cancer
LUO Xing-hong;ZHAO Yan;QIAN Hai-bo;QIN Shu-kui;Simcere Pharmaceutical Co.;Department of Pharmacy;Hainai Provincial Hospital of Traditional Chinese Medicine;Cancer Center;People’s Liberation Army 81 Hospital;

..............page:1525-1531

Progress towards the clinical application of class Ⅲ antiarrhythmic agents for controlling perioperative rapid ventricular rate of atrial fibrillation
ZONG Ya-nan;ZHANG Li-ping;Department of Anesthesiology;Peking University Third Hospital;

..............page:1532-1535+1545

Hemocidins:a new type of antimicrobial peptides derived from hemoproteins
CHEN Xiang;NIU Rong-li;Molecular Medicine Engineering Research Center of the Ministery of Education;Institute of Molecular Medicine;Huaqiao University;

..............page:1536-1539+1556

Photodynamic therapy for cancer treatment and the new antitumor photosensitizer sinoporphyrin sodium
FANG Qi-cheng;Institute of Materia Medica;Chinese Academy of Medical Sciences & Peking Union Medical College;

..............page:1540-1545

Construction of quality control system in clinical anti-tumor drug trials
ZHAO Shu-hua;JIANG Min;National Drug Clinical Trial Center Office;Peking University Cancer Hospital & Institute;

..............page:1546-1548

Methods for the prediction of maximum recommended first-in-human starting dose
WEI Min-ji;HOU Jie;ZHAO Cai-yun;L Yuan;Institute of Clinical Pharmacology;First Hospital;Peking University;Teda International Cardiovascular Hospital;

..............page:1549-1552

Status and duties of clinical research nurse
JIN Yan;ZHANG Qing-yuan;ZHANG Guo-li;GUO Li-bo;YUAN Li-jie;Cancer Hospital Affiliated to Harbin Medical University;

..............page:1553-1556

Analysis of efficacy and influencing factors of icotinib hydrochloride for the treatment of pretreated advanced non-small cell lung cancer
NONG Jing-ying;WANG Jing-hui;YANG Xin-jie;ZHANG Hui;LI Xi;WU Yu-hua;L Jia-lin;QIN Na;ZHANG Quan;ZHANG Shu-cai;Department of Medical Oncology;Beijing Chest Hospital;Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute;

..............page:1557-1561

Determination of oil /water partition coefficient of rasagiline mesylate
SUN Yong-qiang;YAN Yi-min;TU Yong-rui;FENG Xiao-hui;JIANG Wei;WANG Ju-xiang;QI Qi;Changzhou Siyao Pharmaceuticals Co.;Ltd.;

..............page:1562-1564+1573

Predicting nephrotoxicity of drugs using mathematical models
WANG Xin-zhou;ZHU Yong-liang;JIN Ruo-min;LIU Jing-ge;QIAN Xiang-ping;YAO Guang-tao;YE Zu-guang;Suzhou NeuPharma Co.;Ltd.;Shanghai University of Traditional Chinese Medicine;Soochow University;China Academy of Chinese Medical Sciences;

..............page:1565-1568+1578

Synergistic attenuated antitumor effect of Ginkgo biloba exocarp extracts combined with cis-dichlorodiamineplatinum in S180 tumor-bearing mice
CHEN Ying;MAO Lei-lei;HU Bi-yuan;CHEN Hua-sheng;XU Ai-hua;Medical College;Yangzhou University;

..............page:1569-1573

Synthesis of the type 2 anti-diabetic drug sitagliptin phosphate
L Cheng-lin;SHEN Fang-liang;SUN Xin-zhe;ZHANG Xing-xian;College of Pharmaceutical Sciences;Zhejiang University of Technology;

..............page:1574-1578

Simultaneous extraction of two kinds of active ingredients from Salviae Miltiorrhizae Radix et Rhizoma by herbal flash extraction
ZHAI Yong-song;LIU Shu-lin;GAO Zi-chun;ZHENG Hai-yun;GONG Mu-xin;School of Traditional Chinese Medicine;Capital Medical University;Sinopharm Medicine Holding Beijing Co.Ltd;Shijingshan Hospital of Traditional Chinese Medicine;Traditional Chinese Medicine Science and Technology Cooperation Center of CACMS;

..............page:1579-1582+1586

Effects of pH,humidity and light on the stability of sitafloxacin
ZHANG Jie;ZHANG Lu;QIU Li-peng;CHENG Liang;CHENG Li-fang;MIAO De-zu;CHEN Da-wei;School of Pharmacy;Soochow University;School of Pharmacy;Shenyang Pharmaceutical University;ReYoung Pharmaceutical Co.;Ltd.;

..............page:1583-1586

Data analysis of monitoring for 4 therapeutic drugs in children’s hospital
LI Wen-jing;XU Jin;XU Jing;ZHOU Ji;JI Xing;Department of Pharmacy;Nanjing Children’s Hospital Affiliated to Nanjing Medical University;

..............page:1587-1592

Slnopharm A-THINK Pharmaceutical Co.,Ltd

..............page:1593

China Biological Products Annual Conference 2014

..............page:1594